Q1 2015 – An exciting quarter for the pharma industry – Financial Times

Q12015HealthcareDeals

Is bigger better?

During the 1st quarter of 2015, the total deal value in the healthcare industry walked through the ceiling of USD 90 billion… Patent expiries looming on the horizon were one of the main rationale behind this M&A fever.

Some of the Q1 2015 biggest deals:

  • AbbVie & Pharmacyclics – USD 21 billion
  • Pfizer & Hospira – USD 16.8 billion
  • Valean & Salix Pharmaceuticals – USD 15.8 billion
  • UnitedHealth & Catamaran – USD 12.8 billion

Securing valuable and strategic assets seemed crucial in these last moves. But the prices paid were quite high.

FT Article    Bloomberg Article

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s